DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells

被引:0
|
作者
Yegor Smurnyy
Mi Cai
Hua Wu
Elizabeth McWhinnie
John A Tallarico
Yi Yang
Yan Feng
机构
[1] Developmental and Molecular Pathways,
[2] Novartis Institutes for Biomedical Research,undefined
来源
Nature Chemical Biology | 2014年 / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Drug-resistance mutations provide a classical means to identify biological targets of small molecules. A combination of next-generation DNA sequencing with CRISPR-Cas9 genome editing confirms the targets of 6-thioguanine and triptolide and offers a general approach for target identification in cells.[graphic not available: see fulltext]
引用
收藏
页码:623 / 625
页数:2
相关论文
共 50 条
  • [21] CRISPR-cas9 gene editing in undergraduate laboratory experience
    Kee, H. Lynn
    Pieczynski, Jay
    FASEB JOURNAL, 2019, 33
  • [22] Gene editing for the treatment of lung cancer (CRISPR-Cas9)
    Castillo, Andres
    COLOMBIA MEDICA, 2016, 47 (04): : 178 - 180
  • [23] Treatment by CRISPR-Cas9 Gene Editing - A Proof of Principle
    Malech, Harry L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03): : 286 - 287
  • [24] NOBEL PRIZE FOR CHEMISTRY Gene Editing with CRISPR-Cas9
    Welter, Kira
    CHEMIE IN UNSERER ZEIT, 2020, 54 (06) : 346 - 350
  • [25] Gene editing by SSB/CRISPR-Cas9 ribonucleoprotein in bacteria
    Chai, Ran
    Sun, Wenying
    Xu, Zhixu
    Yao, Xinding
    Chen, Shanshan
    Wang, Haifeng
    Guo, Jiaxiang
    Zhang, Qi
    Yang, Yanqing
    Li, Tao
    Chen, Shichang
    Qiu, Liyou
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 278
  • [26] CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
    Gillmore, Julian D.
    Gane, Ed
    Taubel, Jorg
    Kao, Justin
    Fontana, Marianna
    Maitland, Michael L.
    Seitzer, Jessica
    O'Connell, Daniel
    Walsh, Kathryn R.
    Wood, Kristy
    Phillips, Jonathan
    Xu, Yuanxin
    Amaral, Adam
    Boyd, Adam P.
    Cehelsky, Jeffrey E.
    McKee, Mark D.
    Schiermeier, Andrew
    Harari, Olivier
    Murphy, Andrew
    Kyratsous, Christos A.
    Zambrowicz, Brian
    Soltys, Randy
    Gutstein, David E.
    Leonard, John
    Sepp-Lorenzino, Laura
    Lebwohl, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 493 - 502
  • [27] CRISPR-Cas9 DNA Base-Editing and Prime-Editing
    Kantor, Ariel
    McClements, Michelle E.
    MacLaren, Robert E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 22
  • [28] gRNA validation for wheat genome editing with the CRISPR-Cas9 system
    Arndell, Taj
    Sharma, Niharika
    Langridge, Peter
    Baumann, Ute
    Watson-Haigh, Nathan S.
    Whitford, Ryan
    BMC BIOTECHNOLOGY, 2019, 19 (01)
  • [29] The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells
    Lee, Ciaran M.
    Cradick, Thomas J.
    Bao, Gang
    MOLECULAR THERAPY, 2016, 24 (03) : 645 - 654
  • [30] Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing
    Leibowitz, Mitchell L.
    Papathanasiou, Stamatis
    Doerfler, Phillip A.
    Blaine, Logan J.
    Sun, Lili
    Yao, Yu
    Zhang, Cheng-Zhong
    Weiss, Mitchell J.
    Pellman, David
    NATURE GENETICS, 2021, 53 (06) : 895 - +